Literature DB >> 22000585

Insulin clearance is different in men and women.

Michael D Jensen1, Soren Nielsen, Nidhi Gupta, Rita Basu, Robert A Rizza.   

Abstract

Insulin is often infused based upon total body weight (TBW) or fat-free mass (FFM) for glucose clamp protocols. We observed greater insulin concentrations in men than women using this approach and examined whether splanchnic insulin extraction accounts for the differences. Whole-body insulin clearance was measured during a pancreatic clamp study (somatostatin to inhibit islet hormone secretion) including 13 adults (6 men); and whole-body insulin clearance was measured during a euglycemic, hyperinsulinemic clamp study including 27 adults (13 men). Femoral artery and hepatic vein blood samples were collected to measure splanchnic insulin balance. For the pancreatic clamp study, insulin was infused at rates of 0.5, 1.0, and 2.0 mU/kg of TBW per minute; and for the euglycemic, hyperinsulinemic clamp study, insulin was infused at 2.5 mU/kg of FFM per minute. Significantly greater arterial insulin concentrations were found in men than women. Splanchnic plasma flow was similar in men and women in both protocols. Splanchnic insulin extraction and the fraction of infused insulin removed by splanchnic bed were significantly greater in men than in women. However, whole-body insulin clearance was greater in women than men. Infusing insulin per body weight or FFM results in higher plasma insulin concentrations in men than women. Splanchnic insulin extraction is greater in men, indicating that greater peripheral insulin clearance in women accounts for the sex differences we observed. This finding has implications for insulin clamp study design and raises the question of which tissues take up more insulin in women. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22000585      PMCID: PMC3274596          DOI: 10.1016/j.metabol.2011.08.009

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  35 in total

1.  Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics.

Authors:  M M Hennes; E Shrago; A H Kissebah
Journal:  Int J Obes       Date:  1990-10

2.  Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity.

Authors:  C Macor; A Ruggeri; P Mazzonetto; G Federspil; C Cobelli; R Vettor
Journal:  Metabolism       Date:  1997-02       Impact factor: 8.694

3.  Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance.

Authors:  Mark O Goodarzi; Jinrui Cui; Yii-Der I Chen; Willa A Hsueh; Xiuqing Guo; Jerome I Rotter
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-31       Impact factor: 4.310

Review 4.  Hepatic metabolism of insulin.

Authors:  W C Duckworth; F G Hamel; D E Peavy
Journal:  Am J Med       Date:  1988-11-28       Impact factor: 4.965

5.  Renal metabolism of C-peptide in man.

Authors:  I Zavaroni; G Deferrari; R Lugari; E Bonora; G Garibotto; E Dall'Aglio; C Robaudo; A Gnudi
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

6.  Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man.

Authors:  W Waldhäusl; P Bratusch-Marrain; S Gasic; A Korn; P Nowotny
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

7.  Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man.

Authors:  J H Henriksen; B Tronier; J B Bülow
Journal:  Metabolism       Date:  1987-05       Impact factor: 8.694

8.  Subcutaneous adipose tissue blood flow in the abdominal and femoral regions in obese women: effect of fasting.

Authors:  P Engfeldt; B Linde
Journal:  Int J Obes Relat Metab Disord       Date:  1992-11

9.  Quantitative study of insulin secretion and clearance in normal and obese subjects.

Authors:  K S Polonsky; B D Given; L Hirsch; E T Shapiro; H Tillil; C Beebe; J A Galloway; B H Frank; T Karrison; E Van Cauter
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

10.  Insulin degradation by adipose tissue is increased in human obesity.

Authors:  I Rafecas; J A Fernández-López; I Salinas; X Formiguera; X Remesar; M Foz; M Alemany
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

View more
  5 in total

Review 1.  Different physiological mechanisms underlie an adverse cardiovascular disease risk profile in men and women.

Authors:  Alan Fappi; Bettina Mittendorfer
Journal:  Proc Nutr Soc       Date:  2019-07-25       Impact factor: 6.297

2.  Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.

Authors:  Amy Claxton; Laura D Baker; Charles W Wilkinson; Emily H Trittschuh; Darla Chapman; G Stennis Watson; Brenna Cholerton; Stephen R Plymate; Matthew Arbuckle; Suzanne Craft
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

3.  Gender-specific differences in diabetic neuropathy in BTBR ob/ob mice.

Authors:  Phillipe D O'Brien; Junguk Hur; Nicholas J Robell; John M Hayes; Stacey A Sakowski; Eva L Feldman
Journal:  J Diabetes Complications       Date:  2015-10-03       Impact factor: 2.852

4.  Lower insulin clearance is associated with increased risk of type 2 diabetes in Native Americans.

Authors:  Mujtaba H Shah; Paolo Piaggi; Helen C Looker; Ethan Paddock; Jonathan Krakoff; Douglas C Chang
Journal:  Diabetologia       Date:  2021-01-06       Impact factor: 10.122

5.  Plasma IL-1Ra: linking hyperapoB to risk factors for type 2 diabetes independent of obesity in humans.

Authors:  S Bissonnette; N Saint-Pierre; V Lamantia; Y Cyr; H Wassef; M Faraj
Journal:  Nutr Diabetes       Date:  2015-09-28       Impact factor: 5.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.